L-Carnitine
SupplementMedical evidence shows moderate to good indication-specific effects (heart failure [s4], fertility [s7]), whereas the community evaluates the substance primarily as a fat burner and frequently reports disappointment in that context [c3, c4]. The discrepancy arises from a mismatch between clinically supported indications and popular marketing claims.
Unlock full information
Dosages, side effects, studies and more — free after registration.
Register for freeRating Scales
TL;DR
L-carnitine is not a fat burner — the most clinically meaningful data come from heart failure research (improved LVEF across 7 RCTs) and male fertility (+10.72% sperm motility), not weight loss (WMD -1.21 kg across 37 RCTs: statistically significant, practically irrelevant). EFSA rejected all health claims in 2018. Anyone supplementing above 3 g/day should be aware of the elevated TMAO risk — a concern increasingly taken seriously in biohacking communities.
Description
L-Carnitine transports long-chain fatty acids into mitochondria for energy production. Evidence for weight loss is weak; stronger data exist for heart failure and male fertility [s1, s2, ...
L-Carnitine is an endogenous nitrogen-containing compound biosynthesized from the amino acids lysine and methionine in the liver, kidneys, and brain [s1]. The body stores L-carnitine predominantly in cardiac and skeletal muscle. Its primary physiological function is the transport of long-chain acyl-CoA compounds across the inner mitochondrial membrane for subsequent beta-oxidation [s2]. As a dietary supplement, L-carnitine is marketed mainly for weight reduction, athletic performance enhancement, cardiovascular health, and male fertility. Clinical evidence varies considerably by indication: - **Weight reduction**: A meta-analysis of 37 RCTs (n=2,038) demonstrated a statistically significant but clinically modest reduction in body weight (WMD -1.21 kg) [s3]. The German Consumer Advice Centre (Verbraucherzentrale Deutschland) considers the evidence insufficient for practical recommendations [s14]. - **Athletic performance**: Oral supplementation barely increases muscle carnitine concentrations under normal conditions, as the transporter is already saturated [s14]. Intravenous or insulin-stimulated uptake shows stronger effects in controlled studies [s6]. - **Heart failure and cardiovascular outcomes**: A meta-analysis of 7 RCTs (n=862) in chronic heart failure demonstrated significant improvements in left ventricular ejection fraction and reductions in BNP levels [s4]. In myocardial infarction patients, L-carnitine reduced angina attacks but had no effect on heart failure or reinfarction [s5]. - **Male fertility**: Multiple meta-analyses show consistent improvements in sperm motility (+10.72%) and pregnancy rates in idiopathic male infertility [s7, s8]. - **TMAO risk**: Gut microbiota can metabolize L-carnitine to trimethylamine (TMA), which is hepatically oxidized to TMAO. Elevated TMAO levels are associated with atherosclerosis risk [s9, s10]. The...
Legal Status (DE)
In Germany, Austria, and Switzerland, L-carnitine is freely marketable as an over-the-counter dietary supplement (DS). L-Carnitine is listed as a permitted ingredient under EU Dietary Supplements Directive 2002/46/EC [s12]. EFSA has not approved any health claim for L-carnitine to date (rejection in 2018 for "contribution to normal lipid metabolism") [s13]. As a prescription medicinal product, L-carnitine is approved in Germany under the brand name Carnitor® for primary and secondary carnitine deficiency states [s12].
Mechanism of Action
L-Carnitine fulfills several metabolic functions [s1, s2]: 1. **Fatty acid transport**: L-Carnitine forms acylcarnitine conjugates with long-chain acyl-CoA esters, which are transported across the inner mitochondrial membrane by carnitine palmitoyltransferase (CPT-I and CPT-II). The fatty acids are then released for beta-oxidation [s2]. 2. **Buffering of the acetyl-CoA/CoA ratio**: L-Carnitine accepts acetyl groups (→ acetylcarnitine), thereby regulating the mitochondrial acetyl-CoA/free CoA ratio. This enables cells to switch flexibly between carbohydrate and fatty acid metabolism [s1, s2]. 3. **Antioxidant activity**: L-Carnitine reduces oxidative stress by activating antioxidant enzymes (catalase, glutathione peroxidase, dismutase) and inhibiting lipid peroxidation [s8]. 4. **Cardioprotective mechanisms**: In heart failure, L-carnitine compensates for elevated myocardial acylcarnitine levels, improves mitochondrial efficiency, and reduces oxidative stress in cardiac muscle [s4]. 5. **TMAO formation (safety aspect)**: Gut bacteria (Bacteroidetes, Firmicutes in omnivorous diets) metabolize L-carnitine to trimethylamine (TMA). The liver oxidizes TMA to TMAO, which has been associated with promotion of atherosclerosis in animal and cohort studies [s9, s10]. Vegetarians/vegans produce significantly less TMAO from carnitine due to differing gut microbiota [s10].
Dosing
Allgemeine Supplementierung / Energiestoffwechsel
- Dose
- 500–2,000 mg L-carnitine
- Frequency
- 1–2× täglich
- Route
- oral
- Duration
- fortlaufend
- Timing
- 30 minutes before training or with a meal
- With food
- optional
Chronische Herzinsuffizienz (klinisch)
- Dose
- 1,500–3,000 mg L-carnitine daily
- Frequency
- aufgeteilt auf 2–3 Dosen
- Route
- oral
- Duration
- 12 Wochen bis fortlaufend unter ärztlicher Aufsicht
- Timing
- With meals
- With food
- empfohlen
Männliche Infertilität (idiopathisch)
- Dose
- 1,000–2,000 mg L-carnitine + 500–1,000 mg acetyl-L-carnitine
- Frequency
- täglich
- Route
- oral
- Duration
- 12–24 Wochen
- Timing
- With meals
- With food
- empfohlen
Sportliche Leistung (mit Kohlenhydraten)
- Dose
- 2,000 mg L-carnitine together with 80 g carbohydrates
- Frequency
- 2× täglich
- Route
- oral
- Duration
- mindestens 12 Wochen
- Timing
- With carbohydrate-rich meals (elevated insulin levels improve muscle uptake)
- With food
- empfohlen
Up to 2,000 mg daily is considered well tolerated for most adults [s15]. Doses above 3,000 mg daily are associated with increased TMAO risk [s11]. Clinical studies have used up to 4,500 mg/day without serious adverse events [s15]. No official EU/BfR upper limit for L-carnitine in dietary supplements has been established to date.
Muscle uptake of orally supplemented L-carnitine is limited under normal conditions, as the transporter is already saturated by endogenous carnitine. Concurrent insulin stimulation via carbohydrate co-ingestion significantly improves uptake [s6].
Side Effects
| Side Effect | Frequency | Severity |
|---|---|---|
| Gastrointestinale Beschwerden (Übelkeit, Durchfall, Dyspepsie) More frequently reported at doses ≥2,000 mg. Diarrhea and dyspepsia occurred more often than placebo in controlled studies [s15]. | gelegentlich | leicht |
| Fischiger Körper- und Atemgeruch (durch TMA-Bildung) Arises from bacterial metabolism to TMA in the gut. More frequent at higher doses and with an omnivorous diet [s9, s11]. | gelegentlich | leicht |
| Erhöhte TMAO-Plasmaspiegel (potenziell atherogen) Long-term or high-dose intake (>3 g/day) promotes TMAO formation, which has been associated with increased cardiovascular risk in cohort studies. Clinical relevance at moderate supplementation remains controversial [s9, s10]. | gelegentlich | moderat |
| Krampfanfälle (seltene Berichte) Individual case reports of seizures in persons with pre-existing conditions. Mechanism unclear; caution advised in patients with a history of seizures [s15]. | selten | schwer |
| Erhöhte Blutungsneigung (Interaktion mit Warfarin) L-carnitine can potentiate the anticoagulant effect of warfarin and increase INR [s15]. | selten | moderat |
Contraindications
Accumulation of TMAO and acylcarnitine esters is possible due to impaired renal excretion. Dialysis patients frequently exhibit carnitine deficiency (substitution may be medically indicated in this context, but only under medical supervision) [s1].
Rare reports of seizures with L-carnitine supplementation. Caution advised in pre-existing epilepsy [s15].
L-carnitine may antagonize thyroid hormone action and worsen metabolism in hypothyroidism. Clinical relevance has only been described at very high doses [s1].
Interactions
Synergistic
Concurrent carbohydrate intake significantly increases insulin-mediated uptake of L-carnitine into muscle cells. In an RCT, the combination (2 g L-carnitine + 80 g carbohydrates 2×/day over 24 weeks) improved body composition [s6].
The combination of L-carnitine and acetyl-L-carnitine showed stronger effects on sperm motility and pregnancy rate than L-carnitine alone in meta-analyses of male infertility [s7].
L-carnitine and CoQ10 act synergistically on mitochondrial energy production. L-carnitine transports fatty acids into the mitochondria, while CoQ10 supports the electron transport chain. The combination is used particularly in cardiac disease, ME/CFS, and mitochondrial dysfunction.
The combination of L-carnitine (as ALCAR) and alpha-lipoic acid demonstrates synergistic antioxidant and neuroprotective effects in animal studies. Both substances jointly support mitochondrial function and may attenuate age-related cognitive decline.
Caution
L-carnitine may increase INR and prolong bleeding time. Regular INR monitoring during concurrent use is recommended; dose adjustment of the anticoagulant may be necessary [s15].
L-carnitine may act as an antagonist of thyroid hormone action and impair treatment efficacy in hypothyroidism [s1].
Studies
Tier A — High Evidence
Tier B — Moderate Evidence
Community Evidence
Top reported benefits
- Increased energy sensation during training (especially ALCAR)
- Improved endurance performance in cycling and running
- Reduction of muscle soreness after intense training
- Mild support for weight reduction in combination with exercise
- Improved mood and mental clarity (especially Acetyl-L-Carnitine)
Top reported issues
- No perceptible effect on weight loss without a caloric deficit
- Fishy body or breath odor at higher doses
- Gastrointestinal complaints (nausea, diarrhea) at >2 g/day
- Disappointed expectations due to fat-burner marketing
- Uncertainty regarding TMAO and cardiovascular risk
A substantial portion of the community expresses skepticism toward fat-burner claims, emphasizing that L-carnitine does not effectively contribute to weight loss without a concurrent caloric deficit [c3, c4]. TMAO risk is increasingly discussed in biohacking forums, with the clinical relevance of moderate supplementation remaining controversial [c1, c2]. German consumer forums highlight the absence of approved health claims [c4].
Scientific Sources
- L-carnitine--metabolic functions and meaning in humans life
Pekala J, Patkowska-Sokoła B, Bodkowski R, et al. (2011). Current Drug MetabolismBPMID:21561431DOI - Revisiting the Role of Carnitine in Heart Disease Through the Lens of the Gut Microbiota
Papandreou C, Bulló M, Hernández-Alonso P, et al. (2024). NutrientsBDOI - Gut microbiota metabolism of L-carnitine and cardiovascular risk
Koeth RA, Wang Z, Levison BS, et al. (2013). Nature MedicineBPMID:24267266DOI - Directive 2002/46/EC of the European Parliament and of the Council on the approximation of the laws of the Member States relating to food supplements
European Parliament, Council of the European Union (2002). Official Journal of the European CommunitiesALink - L-carnitine and contribution to normal lipid metabolism: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
EFSA Panel on Dietetic Products, Nutrition and Allergies (2018). EFSA JournalADOI - Ohne L-Carnitin keine Fettverbrennung?
Verbraucherzentrale Deutschland (2023). Verbraucherzentrale.deBLink - L-Carnitine: Overview, Uses, Side Effects, Precautions, Interactions, Dosing and Reviews
Natural Medicines Database / WebMD Editorial Staff (2024). WebMD / Natural MedicinesBLink - The effects of L-carnitine supplementation on cardiovascular risk factors in participants with impaired glucose tolerance and diabetes: a systematic review and dose-response meta-analysis
Gheysari R, Nikbaf-Shandiz M, Hosseini AM, Rasaei N, Hosseini S, Bahari H, Asbaghi O, Rastgoo S, Goudarzi K, Shiraseb F, Behmadi R (2024). Diabetology & Metabolic SyndromeCPMID:39085073DOI - Clinical Effects of L-Carnitine Supplementation on Physical Performance in Healthy Subjects, the Key to Success in Rehabilitation: A Systematic Review and Meta-Analysis from the Rehabilitation Point of View
Vecchio M et al. (2021). Journal of Functional Morphology and KinesiologyCPMID:34904601DOI - The effect of L-carnitine supplementation on lipid profile in adults: an umbrella meta-analysis on interventional meta-analyses
Musazadeh V, Alinejad H, Kouhi Esfahani N, Kavyani Z, Keramati M, Roshanravan N, Mosharkesh E, Dehghan P (2023). Frontiers in NutritionCPMID:37688462DOI - Propionyl-L-carnitine for intermittent claudication
Deckert J et al. (Cochrane Vascular Group) (2021). Cochrane Database of Systematic ReviewsCPMID:34954832DOI - The bright and the dark sides of L-carnitine supplementation: a systematic review
Sawicka AK, Renzi G, Olek RA (2020). Journal of the International Society of Sports NutritionAPMID:33317540DOI - Effects of l-carnitine supplementation on weight loss and body composition: A systematic review and meta-analysis of 37 randomized controlled clinical trials with dose-response analysis
Talenezhad N, Mohammadi M, Ramezani-Jolfaie N, et al. (2020). Clinical Nutrition ESPENAPMID:32359762DOI - Efficacy and Safety of L-Carnitine Treatment for Chronic Heart Failure: A Meta-Analysis of Randomized Controlled Trials
Song X, Qu H, Yang Z, et al. (2017). BioMed Research InternationalAPMID:28470012DOI - L-carnitine in the secondary prevention of cardiovascular disease: systematic review and meta-analysis
DiNicolantonio JJ, Lavie CJ, Fares H, et al. (2013). Mayo Clinic ProceedingsAPMID:23597877DOI - Skeletal muscle carnitine loading increases energy expenditure, modulates fuel metabolism gene networks and prevents body fat accumulation in humans
Stephens FB, Wall BT, Marimuthu K, et al. (2013). The Journal of PhysiologyAPMID:23129794DOI - l-carnitine and l-acetylcarnitine supplementation for idiopathic male infertility
Agarwal A, Leisegang K, Sengupta P, et al. (2020). Reproduction and FertilityAPMID:35118398DOI - Effect of L-carnitine and/or L-acetyl-carnitine in nutrition treatment for male infertility: a systematic review
Lenzi A, Sgrò P, Salacone P, et al. (2004). Asian Journal of AndrologyAPMID:17392136DOI - l-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans
Koeth RA, Lam-Galvez BR, Kirsop J, et al. (2019). Journal of Clinical InvestigationBPMID:30530985DOI
Community Sources
Storage
Unopened
Store dry and cool at room temperature (15–25 °C), protected from light and moisture.
Opened
Capsule/tablet form: keep container tightly closed. Powder form: strictly avoid moisture, as the substance is hygroscopic.
Notes
Liquid L-carnitine formulations should be refrigerated after opening and consumed within 4 weeks.